BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 9485312)

  • 21. Identification and characterization of DEN1, a deneddylase of the ULP family.
    Gan-Erdene T; Nagamalleswari K; Yin L; Wu K; Pan ZQ; Wilkinson KD
    J Biol Chem; 2003 Aug; 278(31):28892-900. PubMed ID: 12759362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The amino-acid substituents of dipeptide substrates of cathepsin C can determine the rate-limiting steps of catalysis.
    Rubach JK; Cui G; Schneck JL; Taylor AN; Zhao B; Smallwood A; Nevins N; Wisnoski D; Thrall SH; Meek TD
    Biochemistry; 2012 Sep; 51(38):7551-68. PubMed ID: 22928782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitin C-terminal hydrolases cleave isopeptide- and peptide-linked ubiquitin from structured proteins but do not edit ubiquitin homopolymers.
    Bett JS; Ritorto MS; Ewan R; Jaffray EG; Virdee S; Chin JW; Knebel A; Kurz T; Trost M; Tatham MH; Hay RT
    Biochem J; 2015 Mar; 466(3):489-98. PubMed ID: 25489924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conservation and developmental expression of ubiquitin isopeptidases in Schistosoma mansoni.
    Pereira RV; Vieira HG; Oliveira VF; Gomes Mde S; Passos LK; Borges Wde C; Guerra-Sá R
    Mem Inst Oswaldo Cruz; 2014 Feb; 109(1):1-8. PubMed ID: 24271000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationship, kinetic mechanism, and selectivity for a new class of ubiquitin C-terminal hydrolase-L1 (UCH-L1) inhibitors.
    Mermerian AH; Case A; Stein RL; Cuny GD
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3729-32. PubMed ID: 17449248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient kinetic analysis of USP2-catalyzed deubiquitination reveals a conformational rearrangement in the K48-linked diubiquitin substrate.
    Bozza WP; Liang Q; Gong P; Zhuang Z
    Biochemistry; 2012 Dec; 51(50):10075-86. PubMed ID: 23211065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1.
    Yao T; Song L; Xu W; DeMartino GN; Florens L; Swanson SK; Washburn MP; Conaway RC; Conaway JW; Cohen RE
    Nat Cell Biol; 2006 Sep; 8(9):994-1002. PubMed ID: 16906146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The binding site for UCH-L3 on ubiquitin: mutagenesis and NMR studies on the complex between ubiquitin and UCH-L3.
    Wilkinson KD; Laleli-Sahin E; Urbauer J; Larsen CN; Shih GH; Haas AL; Walsh ST; Wand AJ
    J Mol Biol; 1999 Sep; 291(5):1067-77. PubMed ID: 10518943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14.
    Borodovsky A; Kessler BM; Casagrande R; Overkleeft HS; Wilkinson KD; Ploegh HL
    EMBO J; 2001 Sep; 20(18):5187-96. PubMed ID: 11566882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slow-binding inhibition of gamma-glutamyl transpeptidase by gamma-boroGlu.
    Stein RL; DeCicco C; Nelson D; Thomas B
    Biochemistry; 2001 May; 40(19):5804-11. PubMed ID: 11341846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant ubiquitin (UBB+1) associated with neurodegenerative disorders is hydrolyzed by ubiquitin C-terminal hydrolase L3 (UCH-L3).
    Dennissen FJ; Kholod N; Hermes DJ; Kemmerling N; Steinbusch HW; Dantuma NP; van Leeuwen FW
    FEBS Lett; 2011 Aug; 585(16):2568-74. PubMed ID: 21762696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes.
    Rut W; Zmudzinski M; Snipas SJ; Bekes M; Huang TT; Drag M
    Chem Sci; 2020 Jun; 11(23):6058-6069. PubMed ID: 32953009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel chemical inhibitors for ubiquitin C-terminal hydrolase-L3 by virtual screening.
    Hirayama K; Aoki S; Nishikawa K; Matsumoto T; Wada K
    Bioorg Med Chem; 2007 Nov; 15(21):6810-8. PubMed ID: 17761421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substrate binding and catalysis by ubiquitin C-terminal hydrolases: identification of two active site residues.
    Larsen CN; Price JS; Wilkinson KD
    Biochemistry; 1996 May; 35(21):6735-44. PubMed ID: 8639624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substrate recognition and catalysis by UCH-L1.
    Luchansky SJ; Lansbury PT; Stein RL
    Biochemistry; 2006 Dec; 45(49):14717-25. PubMed ID: 17144664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The functions in the progesterone-induced oocyte maturation of toad ubiquitin carboxyl-terminal hydrolase (tUCH) is independent of its UCH activity].
    Sun ZG; Kong WH; Yan S; Gu Z; Zuo JK
    Shi Yan Sheng Wu Xue Bao; 2003 Apr; 36(2):105-12. PubMed ID: 12858507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and characterization of fluorescent ubiquitin derivatives as highly sensitive substrates for the deubiquitinating enzymes UCH-L3 and USP-2.
    Tirat A; Schilb A; Riou V; Leder L; Gerhartz B; Zimmermann J; Worpenberg S; Eidhoff U; Freuler F; Stettler T; Mayr L; Ottl J; Leuenberger B; Filipuzzi I
    Anal Biochem; 2005 Aug; 343(2):244-55. PubMed ID: 15963938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ubiquitin-aldehyde: a general inhibitor of ubiquitin-recycling processes.
    Hershko A; Rose IA
    Proc Natl Acad Sci U S A; 1987 Apr; 84(7):1829-33. PubMed ID: 3031653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A sensitive fluorescence intensity assay for deubiquitinating proteases using ubiquitin-rhodamine110-glycine as substrate.
    Hassiepen U; Eidhoff U; Meder G; Bulber JF; Hein A; Bodendorf U; Lorthiois E; Martoglio B
    Anal Biochem; 2007 Dec; 371(2):201-7. PubMed ID: 17869210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ubiquitin C-terminal hydrolase activity associated with the 26 S protease complex.
    Eytan E; Armon T; Heller H; Beck S; Hershko A
    J Biol Chem; 1993 Mar; 268(7):4668-74. PubMed ID: 8383122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.